Case Report
Published on 27 Oct 2022
Adult hamartoma of the chest wall: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1004837
- 2,223 views
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,930 articles
articles
Review
Published on 27 Oct 2022
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1026020
- 4,606 views
- 14 citations
Review
Published on 27 Oct 2022
Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1027664
- 6,954 views
- 15 citations
Case Report
Published on 26 Oct 2022
Lung adenocarcinoma relapse with emerging EGFR mutation following complete response of small cell lung cancer warrants routine re-biopsy: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1024655
- 2,612 views
- 1 citation
Original Research
Published on 26 Oct 2022
Would the width of a metal rib spreader affect postoperative pain in patients who undergo video-assisted mini-thoracotomy (VAMT)?
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1039737
- 1,777 views
- 3 citations
Original Research
Published on 24 Oct 2022
Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.942964
- 2,737 views
- 2 citations
Original Research
Published on 24 Oct 2022
Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients’ overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1022123
- 4,661 views
- 22 citations
Systematic Review
Published on 24 Oct 2022
The diagnostic significance of blood-derived circRNAs in NSCLC: Systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.987704
- 2,379 views
- 3 citations
Original Research
Published on 21 Oct 2022
Integrative genomic analysis of drug resistance in MET exon 14 skipping lung cancer using patient-derived xenograft models
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1024818
- 4,962 views
- 10 citations
Original Research
Published on 21 Oct 2022
3D deep learning versus the current methods for predicting tumor invasiveness of lung adenocarcinoma based on high-resolution computed tomography images
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.995870
- 4,380 views
- 10 citations
Review
Published on 21 Oct 2022
Meeting an un-MET need: Targeting MET in non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1004198
- 12,011 views
- 21 citations
Original Research
Published on 21 Oct 2022
Association of metastatic nodal size with survival in non-surgical non-small cell lung cancer patients: Recommendations for clinical N staging
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.990540
- 1,455 views
- 2 citations
Review
Published on 21 Oct 2022
Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.984525
- 5,000 views
- 20 citations
Review
Published on 21 Oct 2022
Financial toxicity in lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1004102
- 10,324 views
- 22 citations
Case Report
Published on 20 Oct 2022
Case report: Complete resection of invasive thymoma invading the superior vena cava and right atrium under cardiopulmonary bypass support
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1026524
- 2,280 views
- 1 citation
Original Research
Published on 20 Oct 2022
Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.935672
- 3,691 views
- 5 citations
Review
Published on 19 Oct 2022
The function and clinical implication of circular RNAs in lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.862602
- 5,668 views
- 14 citations
Original Research
Published on 19 Oct 2022
Construction of survival prediction model for elderly esophageal cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1008326
- 2,825 views
- 5 citations
Case Report
Published on 19 Oct 2022
EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1008932
- 3,806 views
- 2 citations
Original Research
Published on 18 Oct 2022
Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.991378
- 1,543 views
- 1 citation
Clinical Trial
Published on 18 Oct 2022
A phase II study of buparlisib in relapsed or refractory thymomas
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.891383
- 2,934 views
- 13 citations
Case Report
Published on 18 Oct 2022
Case report: A case report and literature review about Pathological transformation of lung adenosquamous cell carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1029679
- 2,473 views
- 4 citations
Case Report
Published on 18 Oct 2022
Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.900966
- 3,226 views
- 2 citations
Original Research
Published on 17 Oct 2022
Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.833773
- 4,584 views
- 3 citations